Reported covered position: Intrn, Sen McCain, 94-96; LSA, 96-97
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Facilitating Innovative Nuclear Diagnostics Act of 2023
Client: SIEMENS HEALTHINEERS (FKA VARIAN MEDICAL SYSTEMS, INC.) · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to radiation therapy reimbursement and alternative payment models; issues related to telehealth; issues related to laboratory testing; S. 1544/H.R. 1199 - Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2023.
Facilitating Innovative Nuclear Diagnostics Act of 2023
Client: SIEMENS HEALTHINEERS (FKA VARIAN MEDICAL SYSTEMS, INC.) · Firm: AKIN GUMP STRAUSS HAUER & FELD
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
SIEMENS HEALTHINEERS (FKA VARIAN MEDICAL SYSTEMS, INC.) via AKIN GUMP STRAUSS HAUER & FELD
2023 · fourth_quarter · Q4
Issues related to radiation therapy reimbursement and alternative payment models; issues related to telehealth; issues related to laboratory testing; S. 1544/H.R. 1199 - Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2023.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
Source: Senate LDA
| AKEBIA THERAPEUTICS, INC. |
| 10 |
| 2019–2021 |
| INARI MEDICAL | 10 | 2021–2023 |
| CITY OF HOUSTON | 9 | 2019–2021 |
| FOUNDATION MEDICINE, INC. | 9 | 2015–2017 |
| COALITION FOR EXCELLENCE IN MEDICATION MONITORING | 8 | 2014–2015 |
| ResMed Corp. | 8 | 2020–2023 |
| SEPSIS STAKEHOLDER COALITION | 8 | 2018–2019 |
| HEALTHCARE CHAPLAINCY NETWORK | 7 | 2017–2018 |
| LET'SGETCHECKED | 7 | 2020–2021 |
| ALCRESTA THERAPEUTICS INC | 6 | 2017–2018 |
| AMERICAN COLLEGE OF GASTROENTEROLOGY | 6 | 2014–2020 |
| AMERITOX | 6 | 2014–2015 |
| CENTRIENT PHARMACEUTICALS LLC | 6 | 2020–2021 |
| IMCS GROUP INC. | 6 | 2019–2021 |
| MAINSTAY MEDICAL, LTD. | 6 | 2022–2023 |
| OFW LAW ON BEHALF OF GREENWICH BIOSCIENCES, INC. | 6 | 2017–2018 |
| OWENS & MINOR, INC. | 6 | 2020–2021 |
| CORDANT HEALTH SOLUTIONS | 5 | 2018–2019 |
| EMED, LLC | 5 | 2021–2022 |
| OTSUKA AMERICA PHARMACEUTICAL, INC. | 5 | 2014 |
| SJ MEDCONNECT | 5 | 2022–2023 |
| SYRACUSE UNIVERSITY | 5 | 2019 |
| CALOPTIMA | 4 | 2020–2021 |
| CLEVELAND HEARTLAB, INC. | 4 | 2015–2016 |
| Global Healthcare Exchange, LLC | 4 | 2020 |
| LEGACY HEART CARE | 4 | 2019 |
| Sight Sciences, Inc. | 4 | 2020–2021 |
| TWENTY HOLDINGS INC | 4 | 2021 |
| ATHLETICO PHYSICAL THERAPY | 3 | 2020 |
| Archer Systems, LLC | 3 | 2023 |
| BEECH TREE LABS, INC. | 3 | 2020 |
| BIOGEN, INC. | 3 | 2019 |
| SHATTERPROOF | 3 | 2023 |
| SURGERY PARTNERS | 3 | 2020 |
| XENEX DISINFECTION SERVICES LLC | 3 | 2020 |
| ZELIS HEALTHCARE CORPORATION | 3 | 2019–2020 |
| ABBOTT LABORATORIES | 2 | 2020 |
| DAVITA, INC. | 2 | 2020 |
| EQUIFAX INC | 2 | 2023 |
| EUROAPI | 2 | 2023 |
| LABORATORY CORPORATION OF AMERICA HOLDINGS | 2 | 2023 |
| MACULAR DEGENERATION ASSOCIATION | 2 | 2017 |
| APPRISS, INC. | 1 | 2018 |
| BOOZ ALLEN HAMILTON INC. | 1 | 2022 |
| GLOBAL MEDICAL RESPONSE, INC. | 1 | 2020 |
| HONEYWELL INTERNATIONAL | 1 | 2020 |
| PARTNERSHIP FOR MEDICAID HOME-BASED CARE | 1 | 2023 |
| QNOVIA, INC. | 1 | 2023 |
| SPECTRAPASS | 1 | 2020 |
| WCNSM ENTERPRISE, LLX | 1 | 2022 |
Issues related to radiation therapy reimbursement and alternative payment models; issues related to telehealth; issues related to laboratory testing; S. 1544/H.R. 1199 - Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2023.
Issues regarding Medicare reimbursement for respiratory devices (H.R. 5555 - DMEPOS Relief Act of 2023).
Facilitating Innovative Nuclear Diagnostics Act of 2023
Client: SIEMENS HEALTHINEERS (FKA VARIAN MEDICAL SYSTEMS, INC.) · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to radiation therapy reimbursement and alternative payment models; issues related to telehealth; issues related to laboratory testing; S. 1544/H.R. 1199 - Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2023.
Facilitating Innovative Nuclear Diagnostics Act of 2023
Client: SIEMENS HEALTHINEERS (FKA VARIAN MEDICAL SYSTEMS, INC.) · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to radiation therapy reimbursement and alternative payment models; issues related to telehealth; issues related to laboratory testing; S. 1544/H.R. 1199 - Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2023.
SUPPORT for Patients and Communities Reauthorization Act of 2023
Client: SHATTERPROOF · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to Substance Use Disorder programs; S. 2433 - SUPPORT for Patients and Communities Reauthorization Act of 2023 funding; Issues related to behavioral health.
SUPPORT for Patients and Communities Reauthorization Act of 2023
Client: SHATTERPROOF · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to Substance Use Disorder programs; S. 2433 - SUPPORT for Patients and Communities Reauthorization Act of 2023 funding; Issues related to behavioral health; Methods to assess addiction treatment facilities quality and accessibility, including launch of the "Shatterproof Treatment Atlas" to help patients find treatment options.
Cures 2.0 Act
Client: PARTNERSHIP FOR MEDICAID HOME-BASED CARE · Firm: AKIN GUMP STRAUSS HAUER & FELD
Medicaid home- and community-based services funding; Issues related to funding for Medicaid home and community-based services, alignment of Medicare and Medicaid Programs to protect the dually eligible population, the definition of private duty nursing, and section 409 of H.R. 6000, the Cures 2.0 Act. Centers for Medicare and Medicaid Services Ensuring Access to Medicaid Services (CMS-2442-P) Proposed Rule.
Issues related to Substance Use Disorder programs; S.3476 - SUPPORT Act of 2022 funding; Issues related to behavioral health.
Facilitating Innovative Nuclear Diagnostics Act of 2021
Client: SIEMENS HEALTHINEERS (FKA VARIAN MEDICAL SYSTEMS, INC.) · Firm: AKIN GUMP STRAUSS HAUER & FELD
H.R. 4479, the Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2021; issues related to radiation therapy reimbursement and alternative payment models; issues related to telehealth; issues related to COVID-19 testing; H.R. 4479/S. 2609 - the Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2021.
Facilitating Innovative Nuclear Diagnostics Act of 2021
Client: SIEMENS HEALTHINEERS (FKA VARIAN MEDICAL SYSTEMS, INC.) · Firm: AKIN GUMP STRAUSS HAUER & FELD
H.R. 4479/S. 2609 - the Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2021; issues re: radiation therapy reimbursement and alternative payment models; issues re: telehealth; issues re: COVID-19 testing.
Facilitating Innovative Nuclear Diagnostics Act of 2021
Client: SIEMENS HEALTHINEERS (FKA VARIAN MEDICAL SYSTEMS, INC.) · Firm: AKIN GUMP STRAUSS HAUER & FELD
H.R. 4479/S. 2609 - the Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2021; issues re: radiation therapy reimbursement and alternative payment models; issues re: telehealth; issues re: COVID-19 testing.
Facilitating Innovative Nuclear Diagnostics Act of 2021
Client: SIEMENS HEALTHINEERS (FKA VARIAN MEDICAL SYSTEMS, INC.) · Firm: AKIN GUMP STRAUSS HAUER & FELD
H.R. 4479, the Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2021; issues related to radiation therapy reimbursement and alternative payment models; issues related to telehealth; issues related to COVID-19 testing; H.R. 4479/S. 2609 - the Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2021.
Opioids/substance use; Issues impacting laboratories; Comprehensive Addiction and Recovery Act (CARA) 3.0 (S.987)
Opioids/substance use; laboratories; Comprehensive Addiction and Recovery Act (CARA) 3.0 (S.987)
Opioids/substance use; laboratories; Comprehensive Addiction and Recovery Act (CARA) 3.0 (S.987)
Opioids/substance use; laboratories; Comprehensive Addiction and Recovery Act (CARA) 3.0 (S.987)
Consolidated Appropriations Act, 2021
Client: GLOBAL HEALTHCARE EXCHANGE, LLC · Firm: AKIN GUMP STRAUSS HAUER & FELD
COVID-19 pandemic response; issues related to the health care supply chain; Medical Supplies for Pandemics Act (H.R. 6531); Implementation of CARES Act (P.L. 116-136); Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act (H.R. 6800); Health, Economic Assistance, Liability Protection and Schools (HEALS) Act; Strengthening America's Strategic National Stockpile Act (H.R. 7574); Make PPE in America Act (S. 4578/H.R. 8324); FY 2021 National Defense Authorization Act (H.R. 6395); CASH Act of 2020 (H.R. 9051); FY 2021 Consolidated Appropriations Act (H.R. 133).
Consolidated Appropriations Act, 2021
Client: HILL-ROM · Firm: AKIN GUMP STRAUSS HAUER & FELD
Sec. S965 and GILTI.; COVID-19 tax issues including, Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), the CARES Act (S. 3548/H.R. 748) the HEROES Act (H.R. 6800), Consolidated Appropriations Act, 2021 (H.R. 133)
Consolidated Appropriations Act, 2021
Client: OWENS & MINOR, INC. · Firm: AKIN GUMP STRAUSS HAUER & FELD
COVID-19 pandemic response, supply chain issues and collaboration with federal government; Disaster preparedness for Medicare demonstrations; Implementation of CARES Act (P.L. 116-136); HEROES Act (H.R. 6800); Health, Economic Assistance, Liability Protection and Schools (HEALS) Act; Strengthening America's Strategic National Stockpile Act (H.R. 7574); Make PPE in America Act (S. 4578/H.R. 8324); Medical Supplies for Pandemics Act (H.R. 6531); FY 2021 National Defense Authorization Act (H.R. 6395); FY 2021 Consolidated Appropriations Act (H.R. 133); Issues related to the health care supply chain and COVID-19 response.
Consolidated Appropriations Act, 2021
Client: HILL-ROM · Firm: AKIN GUMP STRAUSS HAUER & FELD
Technology research; Telemedicine and connected care; Remote patient monitoring; Implementation of Patient Protection and Affordable Care Act (H.R. 3590/P.L. 111-148); Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); The implementation of The Medicare Access and CHIP re authorization Act (H.R. 2); Diabetic retinopathy; safe patient handling, FDA reform; Sepsis funding and education; Diabetic Vision Loss and Blindness Prevention Act of 2019 (H.R.5254).; COVID-19 health care legislative and regulatory implementation and funding issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), the CARES Act (S. 3548/H.R. 748) and the HEROES Act (H.R. 6800), Consolidated Appropriations Act, 2021 (H.R. 133)
Consolidated Appropriations Act, 2021
Client: HILL-ROM · Firm: AKIN GUMP STRAUSS HAUER & FELD
Technology research; Telemedicine and connected care; Remote patient monitoring; Implementation of Patient Protection and Affordable Care Act (H.R. 3590/P.L. 111-148); Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); The implementation of The Medicare Access and CHIP re authorization Act (H.R. 2); Diabetic retinopathy; safe patient handling, FDA reform; Sepsis funding and education; Diabetic Vision Loss and Blindness Prevention Act of 2019 (H.R.5254).; COVID-19 health care legislative and regulatory implementation and funding issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), the CARES Act (S. 3548/H.R. 748) and the HEROES Act (H.R. 6800), Consolidated Appropriations Act, 2021 (H.R. 133)
Further Consolidated Appropriations Act, 2020
Client: HILL-ROM · Firm: AKIN GUMP STRAUSS HAUER & FELD
COVID-19 health care issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), and the CARES Act (S. 3548/H.R. 748); Technology research; Telemedicine and connected care; Remote patient monitoring; Implementation of Patient Protection and Affordable Care Act (H.R. 3590/P.L. 111-148); Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); The implementation of The Medicare Access and CHIP re authorization Act (H.R. 2); Diabetic retinopathy; safe patient handling, FDA reform; Sepsis funding and education; Further Consolidated Appropriations Act, 2020, (H.R.1865); Diabetic Vision Loss and Blindness Prevention Act of 2019 (H.R.5254).
Further Consolidated Appropriations Act, 2020
Client: HILL-ROM · Firm: AKIN GUMP STRAUSS HAUER & FELD
COVID-19 health care issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the COVID-19 health care issues issues within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), and the CARES Act (S. 3548/H.R. 748); Implementation of Patient Protection and Affordable Care Act (H.R. 3590/Pub. L. 111-148); Telemedicine and connected care; Remote patient monitoring; Health Care and Education Reconciliation Act (H.R. 4872/Pub. L. 111-152); The implementation of the Medicare Access and CHIP reauthorization Act (H.R. 2); Safe patient handling, FDA reform; Sepsis funding and education; Further Consolidated Appropriations Act, 2020, (H.R.1865); Diabetic Vision Loss and Blindness Prevention Act of 2019 (H.R.5254).; COVID-19 health care issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the COVID-19 health care issues issues within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), the CARES Act (S. 3548/H.R. 748); the HEROES Act (H.R. 6800)
Further Consolidated Appropriations Act, 2020
Client: HILL-ROM · Firm: AKIN GUMP STRAUSS HAUER & FELD
COVID-19 health care issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the COVID-19 health care issues issues within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), and the CARES Act (S. 3548/H.R. 748); Implementation of Patient Protection and Affordable Care Act (H.R. 3590/Pub. L. 111-148); Telemedicine and connected care; Remote patient monitoring; Health Care and Education Reconciliation Act (H.R. 4872/Pub. L. 111-152); The implementation of the Medicare Access and CHIP reauthorization Act (H.R. 2); Safe patient handling, FDA reform; Sepsis funding and education; Further Consolidated Appropriations Act, 2020, (H.R.1865); Diabetic Vision Loss and Blindness Prevention Act of 2019 (H.R.5254).
Further Consolidated Appropriations Act, 2020
Client: HILL-ROM · Firm: AKIN GUMP STRAUSS HAUER & FELD
COVID-19 health care issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the COVID-19 health care issues issues within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), and the CARES Act (S. 3548/H.R. 748); Implementation of Patient Protection and Affordable Care Act (H.R. 3590/Pub. L. 111-148); Telemedicine and connected care; Remote patient monitoring; Health Care and Education Reconciliation Act (H.R. 4872/Pub. L. 111-152); The implementation of the Medicare Access and CHIP reauthorization Act (H.R. 2); Safe patient handling, FDA reform; Sepsis funding and education; Further Consolidated Appropriations Act, 2020, (H.R.1865); Diabetic Vision Loss and Blindness Prevention Act of 2019 (H.R.5254).
Paycheck Protection Program and Health Care Enhancement Act
Client: SURGERY PARTNERS · Firm: AKIN GUMP STRAUSS HAUER & FELD
CARES Act (H.R. 748); Paycheck Protection Program and Health Care Enhancement Act (H.R. 266); To amend title XVIII of the Social Security Act to provide for forgiveness of certain accelerated and advance payments under parts A and B of the Medicare program (H.R. 7292); relief for ASCs related to COVID-19 pandemic outbreak.
Paycheck Protection Program and Health Care Enhancement Act
Client: SURGERY PARTNERS · Firm: AKIN GUMP STRAUSS HAUER & FELD
CARES Act (H.R. 748); Paycheck Protection Program and Health Care Enhancement Act (H.R. 266); Immediate Relief for Rural Facilities and Providers Act of 2020 (S. 3559/H.R. 6365); relief for ASCs related to COVID-19 pandemic outbreak.
Paycheck Protection Program and Health Care Enhancement Act
Client: RESMED CORP. · Firm: AKIN GUMP STRAUSS HAUER & FELD
CARES Act (H.R. 748); Telehealth; Strategic National Stockpile; Paycheck Protection Program and Health Care Enhancement Act (H.R. 266)
Building Our Opportunities to Survive and Thrive Act of 2019
Client: HILL-ROM · Firm: AKIN GUMP STRAUSS HAUER & FELD
COVID-19 health care issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the COVID-19 health care issues issues within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), and the CARES Act (S. 3548/H.R. 748); Implementation of Patient Protection and Affordable Care Act (H.R. 3590/Pub. L. 111-148); Telemedicine and connected care; Remote patient monitoring; Health Care and Education Reconciliation Act (H.R. 4872/Pub. L. 111-152); The implementation of the Medicare Access and CHIP reauthorization Act (H.R. 2); Safe patient handling, FDA reform; Sepsis funding and education; Further Consolidated Appropriations Act, 2020, (H.R.1865); Diabetic Vision Loss and Blindness Prevention Act of 2019 (H.R.5254).; COVID-19 health care issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the COVID-19 health care issues issues within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), the CARES Act (S. 3548/H.R. 748); the HEROES Act (H.R. 6800)
Building Our Opportunities to Survive and Thrive Act of 2019
Client: HILL-ROM · Firm: AKIN GUMP STRAUSS HAUER & FELD
COVID-19 health care issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), and the CARES Act (S. 3548/H.R. 748); Technology research; Telemedicine and connected care; Remote patient monitoring; Implementation of Patient Protection and Affordable Care Act (H.R. 3590/P.L. 111-148); Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); The implementation of The Medicare Access and CHIP re authorization Act (H.R. 2); Diabetic retinopathy; safe patient handling, FDA reform; Sepsis funding and education; Further Consolidated Appropriations Act, 2020, (H.R.1865); Diabetic Vision Loss and Blindness Prevention Act of 2019 (H.R.5254).
Building Our Opportunities to Survive and Thrive Act of 2019
Client: HILL-ROM · Firm: AKIN GUMP STRAUSS HAUER & FELD
Technology research; Telemedicine and connected care; Remote patient monitoring; Implementation of Patient Protection and Affordable Care Act (H.R. 3590/P.L. 111-148); Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); The implementation of The Medicare Access and CHIP re authorization Act (H.R. 2); Diabetic retinopathy; safe patient handling, FDA reform; Sepsis funding and education; Diabetic Vision Loss and Blindness Prevention Act of 2019 (H.R.5254).; COVID-19 health care legislative and regulatory implementation and funding issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), the CARES Act (S. 3548/H.R. 748) and the HEROES Act (H.R. 6800), Consolidated Appropriations Act, 2021 (H.R. 133)
Building Our Opportunities to Survive and Thrive Act of 2019
Client: HILL-ROM · Firm: AKIN GUMP STRAUSS HAUER & FELD
COVID-19 health care issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the COVID-19 health care issues issues within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), and the CARES Act (S. 3548/H.R. 748); Implementation of Patient Protection and Affordable Care Act (H.R. 3590/Pub. L. 111-148); Telemedicine and connected care; Remote patient monitoring; Health Care and Education Reconciliation Act (H.R. 4872/Pub. L. 111-152); The implementation of the Medicare Access and CHIP reauthorization Act (H.R. 2); Safe patient handling, FDA reform; Sepsis funding and education; Further Consolidated Appropriations Act, 2020, (H.R.1865); Diabetic Vision Loss and Blindness Prevention Act of 2019 (H.R.5254).
Building Our Opportunities to Survive and Thrive Act of 2019
Client: HILL-ROM · Firm: AKIN GUMP STRAUSS HAUER & FELD
Technology research; Telemedicine and connected care; Remote patient monitoring; Implementation of Patient Protection and Affordable Care Act (H.R. 3590/P.L. 111-148); Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); The implementation of The Medicare Access and CHIP re authorization Act (H.R. 2); Diabetic retinopathy; safe patient handling, FDA reform; Sepsis funding and education; Diabetic Vision Loss and Blindness Prevention Act of 2019 (H.R.5254).; COVID-19 health care legislative and regulatory implementation and funding issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), the CARES Act (S. 3548/H.R. 748) and the HEROES Act (H.R. 6800), Consolidated Appropriations Act, 2021 (H.R. 133)
Building Our Opportunities to Survive and Thrive Act of 2019
Client: HILL-ROM · Firm: AKIN GUMP STRAUSS HAUER & FELD
COVID-19 health care issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the COVID-19 health care issues issues within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), and the CARES Act (S. 3548/H.R. 748); Implementation of Patient Protection and Affordable Care Act (H.R. 3590/Pub. L. 111-148); Telemedicine and connected care; Remote patient monitoring; Health Care and Education Reconciliation Act (H.R. 4872/Pub. L. 111-152); The implementation of the Medicare Access and CHIP reauthorization Act (H.R. 2); Safe patient handling, FDA reform; Sepsis funding and education; Further Consolidated Appropriations Act, 2020, (H.R.1865); Diabetic Vision Loss and Blindness Prevention Act of 2019 (H.R.5254).
Technology research; Telemedicine and connected care; Remote patient monitoring; Implementation of Patient Protection and Affordable Care Act (H.R. 3590/P.L. 111-148); Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); The implementation of The Medicare Access and CHIP re authorization Act (H.R. 2); Diabetic retinopathy; safe patient handling, FDA reform; Sepsis funding and education; Diabetic Vision Loss and Blindness Prevention Act of 2019 (H.R.5254).; COVID-19 health care legislative and regulatory implementation and funding issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), the CARES Act (S. 3548/H.R. 748) and the HEROES Act (H.R. 6800), Consolidated Appropriations Act, 2021 (H.R. 133)
COVID-19 health care issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the COVID-19 health care issues issues within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), and the CARES Act (S. 3548/H.R. 748); Implementation of Patient Protection and Affordable Care Act (H.R. 3590/Pub. L. 111-148); Telemedicine and connected care; Remote patient monitoring; Health Care and Education Reconciliation Act (H.R. 4872/Pub. L. 111-152); The implementation of the Medicare Access and CHIP reauthorization Act (H.R. 2); Safe patient handling, FDA reform; Sepsis funding and education; Further Consolidated Appropriations Act, 2020, (H.R.1865); Diabetic Vision Loss and Blindness Prevention Act of 2019 (H.R.5254).
Technology research; Telemedicine and connected care; Remote patient monitoring; Implementation of Patient Protection and Affordable Care Act (H.R. 3590/P.L. 111-148); Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); The implementation of The Medicare Access and CHIP re authorization Act (H.R. 2); Diabetic retinopathy; safe patient handling, FDA reform; Sepsis funding and education; Diabetic Vision Loss and Blindness Prevention Act of 2019 (H.R.5254).; COVID-19 health care legislative and regulatory implementation and funding issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), the CARES Act (S. 3548/H.R. 748) and the HEROES Act (H.R. 6800), Consolidated Appropriations Act, 2021 (H.R. 133)
COVID-19 health care issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the COVID-19 health care issues issues within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), and the CARES Act (S. 3548/H.R. 748); Implementation of Patient Protection and Affordable Care Act (H.R. 3590/Pub. L. 111-148); Telemedicine and connected care; Remote patient monitoring; Health Care and Education Reconciliation Act (H.R. 4872/Pub. L. 111-152); The implementation of the Medicare Access and CHIP reauthorization Act (H.R. 2); Safe patient handling, FDA reform; Sepsis funding and education; Further Consolidated Appropriations Act, 2020, (H.R.1865); Diabetic Vision Loss and Blindness Prevention Act of 2019 (H.R.5254).; COVID-19 health care issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the COVID-19 health care issues issues within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), the CARES Act (S. 3548/H.R. 748); the HEROES Act (H.R. 6800)
COVID-19 health care issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), and the CARES Act (S. 3548/H.R. 748); Technology research; Telemedicine and connected care; Remote patient monitoring; Implementation of Patient Protection and Affordable Care Act (H.R. 3590/P.L. 111-148); Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); The implementation of The Medicare Access and CHIP re authorization Act (H.R. 2); Diabetic retinopathy; safe patient handling, FDA reform; Sepsis funding and education; Further Consolidated Appropriations Act, 2020, (H.R.1865); Diabetic Vision Loss and Blindness Prevention Act of 2019 (H.R.5254).
COVID-19 health care issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the COVID-19 health care issues issues within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), and the CARES Act (S. 3548/H.R. 748); Implementation of Patient Protection and Affordable Care Act (H.R. 3590/Pub. L. 111-148); Telemedicine and connected care; Remote patient monitoring; Health Care and Education Reconciliation Act (H.R. 4872/Pub. L. 111-152); The implementation of the Medicare Access and CHIP reauthorization Act (H.R. 2); Safe patient handling, FDA reform; Sepsis funding and education; Further Consolidated Appropriations Act, 2020, (H.R.1865); Diabetic Vision Loss and Blindness Prevention Act of 2019 (H.R.5254).
Safeguarding Medicare Access to Respiratory Therapy Act of 2019
Client: RESMED CORP. · Firm: AKIN GUMP STRAUSS HAUER & FELD
Delay of Round 2021 of the Competitive Bidding Program; SMART Act (H.R. 4945); Coverage policies regarding noninvasive positive pressure ventilation.
Diabetic Vision Loss and Blindness Prevention Act of 2019
Client: HILL-ROM · Firm: AKIN GUMP STRAUSS HAUER & FELD
COVID-19 health care issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the COVID-19 health care issues issues within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), and the CARES Act (S. 3548/H.R. 748); Implementation of Patient Protection and Affordable Care Act (H.R. 3590/Pub. L. 111-148); Telemedicine and connected care; Remote patient monitoring; Health Care and Education Reconciliation Act (H.R. 4872/Pub. L. 111-152); The implementation of the Medicare Access and CHIP reauthorization Act (H.R. 2); Safe patient handling, FDA reform; Sepsis funding and education; Further Consolidated Appropriations Act, 2020, (H.R.1865); Diabetic Vision Loss and Blindness Prevention Act of 2019 (H.R.5254).; COVID-19 health care issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the COVID-19 health care issues issues within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), the CARES Act (S. 3548/H.R. 748); the HEROES Act (H.R. 6800)
Diabetic Vision Loss and Blindness Prevention Act of 2019
Client: HILL-ROM · Firm: AKIN GUMP STRAUSS HAUER & FELD
COVID-19 health care issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), and the CARES Act (S. 3548/H.R. 748); Technology research; Telemedicine and connected care; Remote patient monitoring; Implementation of Patient Protection and Affordable Care Act (H.R. 3590/P.L. 111-148); Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); The implementation of The Medicare Access and CHIP re authorization Act (H.R. 2); Diabetic retinopathy; safe patient handling, FDA reform; Sepsis funding and education; Further Consolidated Appropriations Act, 2020, (H.R.1865); Diabetic Vision Loss and Blindness Prevention Act of 2019 (H.R.5254).
Diabetic Vision Loss and Blindness Prevention Act of 2019
Client: HILL-ROM · Firm: AKIN GUMP STRAUSS HAUER & FELD
COVID-19 health care issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the COVID-19 health care issues issues within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), and the CARES Act (S. 3548/H.R. 748); Implementation of Patient Protection and Affordable Care Act (H.R. 3590/Pub. L. 111-148); Telemedicine and connected care; Remote patient monitoring; Health Care and Education Reconciliation Act (H.R. 4872/Pub. L. 111-152); The implementation of the Medicare Access and CHIP reauthorization Act (H.R. 2); Safe patient handling, FDA reform; Sepsis funding and education; Further Consolidated Appropriations Act, 2020, (H.R.1865); Diabetic Vision Loss and Blindness Prevention Act of 2019 (H.R.5254).
Diabetic Vision Loss and Blindness Prevention Act of 2019
Client: HILL-ROM · Firm: AKIN GUMP STRAUSS HAUER & FELD
Technology research; Telemedicine and connected care; Remote patient monitoring; Implementation of Patient Protection and Affordable Care Act (H.R. 3590/P.L. 111-148); Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); The implementation of The Medicare Access and CHIP re authorization Act (H.R. 2); Diabetic retinopathy; safe patient handling, FDA reform; Sepsis funding and education; Diabetic Vision Loss and Blindness Prevention Act of 2019 (H.R.5254).; COVID-19 health care legislative and regulatory implementation and funding issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), the CARES Act (S. 3548/H.R. 748) and the HEROES Act (H.R. 6800), Consolidated Appropriations Act, 2021 (H.R. 133)
Diabetic Vision Loss and Blindness Prevention Act of 2019
Client: HILL-ROM · Firm: AKIN GUMP STRAUSS HAUER & FELD
COVID-19 health care issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the COVID-19 health care issues issues within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), and the CARES Act (S. 3548/H.R. 748); Implementation of Patient Protection and Affordable Care Act (H.R. 3590/Pub. L. 111-148); Telemedicine and connected care; Remote patient monitoring; Health Care and Education Reconciliation Act (H.R. 4872/Pub. L. 111-152); The implementation of the Medicare Access and CHIP reauthorization Act (H.R. 2); Safe patient handling, FDA reform; Sepsis funding and education; Further Consolidated Appropriations Act, 2020, (H.R.1865); Diabetic Vision Loss and Blindness Prevention Act of 2019 (H.R.5254).
Diabetic Vision Loss and Blindness Prevention Act of 2019
Client: HILL-ROM · Firm: AKIN GUMP STRAUSS HAUER & FELD
Technology research; Telemedicine and connected care; Remote patient monitoring; Implementation of Patient Protection and Affordable Care Act (H.R. 3590/P.L. 111-148); Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); The implementation of The Medicare Access and CHIP re authorization Act (H.R. 2); Diabetic retinopathy; safe patient handling, FDA reform; Sepsis funding and education; Diabetic Vision Loss and Blindness Prevention Act of 2019 (H.R.5254).; COVID-19 health care legislative and regulatory implementation and funding issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), the CARES Act (S. 3548/H.R. 748) and the HEROES Act (H.R. 6800), Consolidated Appropriations Act, 2021 (H.R. 133)
Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020
Client: HILL-ROM · Firm: AKIN GUMP STRAUSS HAUER & FELD
COVID-19 tax issues including, Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), and the CARES Act (S. 3548/H.R. 748); Sec. S965 and GILTI.
Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020
Client: HILL-ROM · Firm: AKIN GUMP STRAUSS HAUER & FELD
COVID-19 health care issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the COVID-19 health care issues issues within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), and the CARES Act (S. 3548/H.R. 748); Implementation of Patient Protection and Affordable Care Act (H.R. 3590/Pub. L. 111-148); Telemedicine and connected care; Remote patient monitoring; Health Care and Education Reconciliation Act (H.R. 4872/Pub. L. 111-152); The implementation of the Medicare Access and CHIP reauthorization Act (H.R. 2); Safe patient handling, FDA reform; Sepsis funding and education; Further Consolidated Appropriations Act, 2020, (H.R.1865); Diabetic Vision Loss and Blindness Prevention Act of 2019 (H.R.5254).; COVID-19 health care issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the COVID-19 health care issues issues within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), the CARES Act (S. 3548/H.R. 748); the HEROES Act (H.R. 6800)
Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020
Client: SENSEONICS INCORPORATED · Firm: AKIN GUMP STRAUSS HAUER & FELD
COVID-19 health care issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), and the CARES Act (S. 3548/H.R. 748)
Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020
Client: MILLENNIUM HEALTH · Firm: AKIN GUMP STRAUSS HAUER & FELD
COVID-19 health care issues including relief funding within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), and the CARES Act (H.R. 748). Issues related to the Paycheck Protection Program.
Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020
Client: HILL-ROM · Firm: AKIN GUMP STRAUSS HAUER & FELD
COVID-19 health care issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), and the CARES Act (S. 3548/H.R. 748); Technology research; Telemedicine and connected care; Remote patient monitoring; Implementation of Patient Protection and Affordable Care Act (H.R. 3590/P.L. 111-148); Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); The implementation of The Medicare Access and CHIP re authorization Act (H.R. 2); Diabetic retinopathy; safe patient handling, FDA reform; Sepsis funding and education; Further Consolidated Appropriations Act, 2020, (H.R.1865); Diabetic Vision Loss and Blindness Prevention Act of 2019 (H.R.5254).
Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020
Client: HILL-ROM · Firm: AKIN GUMP STRAUSS HAUER & FELD
COVID-19 tax issues including, Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), and the CARES Act (S. 3548/H.R. 748); Sec. S965 and GILTI.; the HEROES Act (H.R. 6800).
Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020
Client: HILL-ROM · Firm: AKIN GUMP STRAUSS HAUER & FELD
Technology research; Telemedicine and connected care; Remote patient monitoring; Implementation of Patient Protection and Affordable Care Act (H.R. 3590/P.L. 111-148); Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); The implementation of The Medicare Access and CHIP re authorization Act (H.R. 2); Diabetic retinopathy; safe patient handling, FDA reform; Sepsis funding and education; Diabetic Vision Loss and Blindness Prevention Act of 2019 (H.R.5254).; COVID-19 health care legislative and regulatory implementation and funding issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), the CARES Act (S. 3548/H.R. 748) and the HEROES Act (H.R. 6800), Consolidated Appropriations Act, 2021 (H.R. 133)
Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020
Client: HONEYWELL INTERNATIONAL · Firm: AKIN GUMP STRAUSS HAUER & FELD
COVID-19 health care issues, including supply chain issues, hospitals and other relief funding within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), the CARES Act (S. 3548/H.R. 748), and HEROES Act (HR 6800).
Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020
Client: MILLENNIUM HEALTH · Firm: AKIN GUMP STRAUSS HAUER & FELD
COVID-19 health care issues including relief funding within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), and the CARES Act (H.R. 748).; Paycheck Protection Program.
Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020
Client: HILL-ROM · Firm: AKIN GUMP STRAUSS HAUER & FELD
COVID-19 health care issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the COVID-19 health care issues issues within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), and the CARES Act (S. 3548/H.R. 748); Implementation of Patient Protection and Affordable Care Act (H.R. 3590/Pub. L. 111-148); Telemedicine and connected care; Remote patient monitoring; Health Care and Education Reconciliation Act (H.R. 4872/Pub. L. 111-152); The implementation of the Medicare Access and CHIP reauthorization Act (H.R. 2); Safe patient handling, FDA reform; Sepsis funding and education; Further Consolidated Appropriations Act, 2020, (H.R.1865); Diabetic Vision Loss and Blindness Prevention Act of 2019 (H.R.5254).
Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020
Client: HILL-ROM · Firm: AKIN GUMP STRAUSS HAUER & FELD
Technology research; Telemedicine and connected care; Remote patient monitoring; Implementation of Patient Protection and Affordable Care Act (H.R. 3590/P.L. 111-148); Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); The implementation of The Medicare Access and CHIP re authorization Act (H.R. 2); Diabetic retinopathy; safe patient handling, FDA reform; Sepsis funding and education; Diabetic Vision Loss and Blindness Prevention Act of 2019 (H.R.5254).; COVID-19 health care legislative and regulatory implementation and funding issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), the CARES Act (S. 3548/H.R. 748) and the HEROES Act (H.R. 6800), Consolidated Appropriations Act, 2021 (H.R. 133)
Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020
Client: SENSEONICS INCORPORATED · Firm: AKIN GUMP STRAUSS HAUER & FELD
COVID-19 health care issues including relief funding within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), and the CARES Act (H.R. 748)
Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020
Client: SENSEONICS INCORPORATED · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues relates to Medicare reimbursement for Medicare devices; COVID-19 health care issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), and the CARES Act (S. 3548/H.R. 748)
Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020
Client: HILL-ROM · Firm: AKIN GUMP STRAUSS HAUER & FELD
COVID-19 health care issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the COVID-19 health care issues issues within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), and the CARES Act (S. 3548/H.R. 748); Implementation of Patient Protection and Affordable Care Act (H.R. 3590/Pub. L. 111-148); Telemedicine and connected care; Remote patient monitoring; Health Care and Education Reconciliation Act (H.R. 4872/Pub. L. 111-152); The implementation of the Medicare Access and CHIP reauthorization Act (H.R. 2); Safe patient handling, FDA reform; Sepsis funding and education; Further Consolidated Appropriations Act, 2020, (H.R.1865); Diabetic Vision Loss and Blindness Prevention Act of 2019 (H.R.5254).
Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020
Client: HILL-ROM · Firm: AKIN GUMP STRAUSS HAUER & FELD
Sec. S965 and GILTI.; COVID-19 tax issues including, Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), the CARES Act (S. 3548/H.R. 748) the HEROES Act (H.R. 6800), Consolidated Appropriations Act, 2021 (H.R. 133)
Families First Coronavirus Response Act
Client: HILL-ROM · Firm: AKIN GUMP STRAUSS HAUER & FELD
COVID-19 tax issues including, Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), and the CARES Act (S. 3548/H.R. 748); Sec. S965 and GILTI.
Families First Coronavirus Response Act
Client: HILL-ROM · Firm: AKIN GUMP STRAUSS HAUER & FELD
Sec. S965 and GILTI.; COVID-19 tax issues including, Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), the CARES Act (S. 3548/H.R. 748) the HEROES Act (H.R. 6800), Consolidated Appropriations Act, 2021 (H.R. 133)
Families First Coronavirus Response Act
Client: HILL-ROM · Firm: AKIN GUMP STRAUSS HAUER & FELD
Technology research; Telemedicine and connected care; Remote patient monitoring; Implementation of Patient Protection and Affordable Care Act (H.R. 3590/P.L. 111-148); Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); The implementation of The Medicare Access and CHIP re authorization Act (H.R. 2); Diabetic retinopathy; safe patient handling, FDA reform; Sepsis funding and education; Diabetic Vision Loss and Blindness Prevention Act of 2019 (H.R.5254).; COVID-19 health care legislative and regulatory implementation and funding issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), the CARES Act (S. 3548/H.R. 748) and the HEROES Act (H.R. 6800), Consolidated Appropriations Act, 2021 (H.R. 133)
Families First Coronavirus Response Act
Client: HILL-ROM · Firm: AKIN GUMP STRAUSS HAUER & FELD
COVID-19 health care issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the COVID-19 health care issues issues within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), and the CARES Act (S. 3548/H.R. 748); Implementation of Patient Protection and Affordable Care Act (H.R. 3590/Pub. L. 111-148); Telemedicine and connected care; Remote patient monitoring; Health Care and Education Reconciliation Act (H.R. 4872/Pub. L. 111-152); The implementation of the Medicare Access and CHIP reauthorization Act (H.R. 2); Safe patient handling, FDA reform; Sepsis funding and education; Further Consolidated Appropriations Act, 2020, (H.R.1865); Diabetic Vision Loss and Blindness Prevention Act of 2019 (H.R.5254).; COVID-19 health care issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the COVID-19 health care issues issues within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), the CARES Act (S. 3548/H.R. 748); the HEROES Act (H.R. 6800)
Families First Coronavirus Response Act
Client: HILL-ROM · Firm: AKIN GUMP STRAUSS HAUER & FELD
COVID-19 health care issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), and the CARES Act (S. 3548/H.R. 748); Technology research; Telemedicine and connected care; Remote patient monitoring; Implementation of Patient Protection and Affordable Care Act (H.R. 3590/P.L. 111-148); Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); The implementation of The Medicare Access and CHIP re authorization Act (H.R. 2); Diabetic retinopathy; safe patient handling, FDA reform; Sepsis funding and education; Further Consolidated Appropriations Act, 2020, (H.R.1865); Diabetic Vision Loss and Blindness Prevention Act of 2019 (H.R.5254).
Families First Coronavirus Response Act
Client: MILLENNIUM HEALTH · Firm: AKIN GUMP STRAUSS HAUER & FELD
COVID-19 health care issues including relief funding within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), and the CARES Act (H.R. 748).; Paycheck Protection Program.
Families First Coronavirus Response Act
Client: SENSEONICS INCORPORATED · Firm: AKIN GUMP STRAUSS HAUER & FELD
COVID-19 health care issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), and the CARES Act (S. 3548/H.R. 748)
Families First Coronavirus Response Act
Client: HILL-ROM · Firm: AKIN GUMP STRAUSS HAUER & FELD
COVID-19 health care issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the COVID-19 health care issues issues within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), and the CARES Act (S. 3548/H.R. 748); Implementation of Patient Protection and Affordable Care Act (H.R. 3590/Pub. L. 111-148); Telemedicine and connected care; Remote patient monitoring; Health Care and Education Reconciliation Act (H.R. 4872/Pub. L. 111-152); The implementation of the Medicare Access and CHIP reauthorization Act (H.R. 2); Safe patient handling, FDA reform; Sepsis funding and education; Further Consolidated Appropriations Act, 2020, (H.R.1865); Diabetic Vision Loss and Blindness Prevention Act of 2019 (H.R.5254).
Families First Coronavirus Response Act
Client: HILL-ROM · Firm: AKIN GUMP STRAUSS HAUER & FELD
COVID-19 health care issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the COVID-19 health care issues issues within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), and the CARES Act (S. 3548/H.R. 748); Implementation of Patient Protection and Affordable Care Act (H.R. 3590/Pub. L. 111-148); Telemedicine and connected care; Remote patient monitoring; Health Care and Education Reconciliation Act (H.R. 4872/Pub. L. 111-152); The implementation of the Medicare Access and CHIP reauthorization Act (H.R. 2); Safe patient handling, FDA reform; Sepsis funding and education; Further Consolidated Appropriations Act, 2020, (H.R.1865); Diabetic Vision Loss and Blindness Prevention Act of 2019 (H.R.5254).
Families First Coronavirus Response Act
Client: SENSEONICS INCORPORATED · Firm: AKIN GUMP STRAUSS HAUER & FELD
COVID-19 health care issues including relief funding within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), and the CARES Act (H.R. 748)
Families First Coronavirus Response Act
Client: HONEYWELL INTERNATIONAL · Firm: AKIN GUMP STRAUSS HAUER & FELD
COVID-19 health care issues, including supply chain issues, hospitals and other relief funding within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), the CARES Act (S. 3548/H.R. 748), and HEROES Act (HR 6800).
Families First Coronavirus Response Act
Client: HILL-ROM · Firm: AKIN GUMP STRAUSS HAUER & FELD
COVID-19 tax issues including, Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), and the CARES Act (S. 3548/H.R. 748); Sec. S965 and GILTI.; the HEROES Act (H.R. 6800).
Families First Coronavirus Response Act
Client: MILLENNIUM HEALTH · Firm: AKIN GUMP STRAUSS HAUER & FELD
COVID-19 health care issues including relief funding within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), and the CARES Act (H.R. 748). Issues related to the Paycheck Protection Program.
Families First Coronavirus Response Act
Client: HILL-ROM · Firm: AKIN GUMP STRAUSS HAUER & FELD
Technology research; Telemedicine and connected care; Remote patient monitoring; Implementation of Patient Protection and Affordable Care Act (H.R. 3590/P.L. 111-148); Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); The implementation of The Medicare Access and CHIP re authorization Act (H.R. 2); Diabetic retinopathy; safe patient handling, FDA reform; Sepsis funding and education; Diabetic Vision Loss and Blindness Prevention Act of 2019 (H.R.5254).; COVID-19 health care legislative and regulatory implementation and funding issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), the CARES Act (S. 3548/H.R. 748) and the HEROES Act (H.R. 6800), Consolidated Appropriations Act, 2021 (H.R. 133)
Families First Coronavirus Response Act
Client: SENSEONICS INCORPORATED · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues relates to Medicare reimbursement for Medicare devices; COVID-19 health care issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), and the CARES Act (S. 3548/H.R. 748)
Immediate Relief for Rural Facilities and Providers Act of 2020
Client: SURGERY PARTNERS · Firm: AKIN GUMP STRAUSS HAUER & FELD
CARES Act (H.R. 748); Paycheck Protection Program and Health Care Enhancement Act (H.R. 266); Immediate Relief for Rural Facilities and Providers Act of 2020 (S. 3559/H.R. 6365); relief for ASCs related to COVID-19 pandemic outbreak.
William M. (Mac) Thornberry National Defense Authorization Act for Fiscal Year 2021
Client: XENEX DISINFECTION SERVICES, LLC · Firm: AKIN GUMP STRAUSS HAUER & FELD
Seek utilization of full-germicidal spectrum UV technologies for the COVID-19 pandemic. Outreach regarding National Defense Authorization Act (S. 4049/HR 6395).
William M. (Mac) Thornberry National Defense Authorization Act for Fiscal Year 2021
Client: XENEX DISINFECTION SERVICES, LLC · Firm: AKIN GUMP STRAUSS HAUER & FELD
Seek utilization of full-germicidal spectrum UV technologies for the COVID-19 pandemic. Outreach regarding National Defense Authorization Act (S. 4049/HR 6395).
William M. (Mac) Thornberry National Defense Authorization Act for Fiscal Year 2021
Client: GLOBAL HEALTHCARE EXCHANGE, LLC · Firm: AKIN GUMP STRAUSS HAUER & FELD
COVID-19 pandemic response; issues related to the health care supply chain; Medical Supplies for Pandemics Act (H.R. 6531); Implementation of CARES Act (P.L. 116-136); Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act (H.R. 6800); Health, Economic Assistance, Liability Protection and Schools (HEALS) Act; Strengthening America's Strategic National Stockpile Act (H.R. 7574); Make PPE in America Act (S. 4578/H.R. 8324); FY 2021 National Defense Authorization Act (H.R. 6395); CASH Act of 2020 (H.R. 9051); FY 2021 Consolidated Appropriations Act (H.R. 133).
William M. (Mac) Thornberry National Defense Authorization Act for Fiscal Year 2021
Client: OWENS & MINOR, INC. · Firm: AKIN GUMP STRAUSS HAUER & FELD
COVID-19 pandemic response, supply chain issues and collaboration with federal government; Disaster preparedness for Medicare demonstrations; Implementation of CARES Act (P.L. 116-136); HEROES Act (H.R. 6800); Health, Economic Assistance, Liability Protection and Schools (HEALS) Act; Strengthening America's Strategic National Stockpile Act (H.R. 7574); Make PPE in America Act (S. 4578/H.R. 8324); Medical Supplies for Pandemics Act (H.R. 6531); FY 2021 National Defense Authorization Act (H.R. 6395); FY 2021 Consolidated Appropriations Act (H.R. 133); Issues related to the health care supply chain and COVID-19 response.
Medical Supplies for Pandemics Act of 2020
Client: GLOBAL HEALTHCARE EXCHANGE, LLC · Firm: AKIN GUMP STRAUSS HAUER & FELD
COVID-19 pandemic response; issues related to the health care supply chain; Medical Supplies for Pandemics Act (H.R. 6531); Implementation of CARES Act (P.L. 116-136); Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act (H.R. 6800); Health, Economic Assistance, Liability Protection and Schools (HEALS) Act; Strengthening America's Strategic National Stockpile Act (H.R. 7574); Make PPE in America Act (S. 4578/H.R. 8324); FY 2021 National Defense Authorization Act (H.R. 6395); CASH Act of 2020 (H.R. 9051); FY 2021 Consolidated Appropriations Act (H.R. 133).
Medical Supplies for Pandemics Act of 2020
Client: OWENS & MINOR, INC. · Firm: AKIN GUMP STRAUSS HAUER & FELD
COVID-19 pandemic response, supply chain issues and collaboration with federal government; Disaster preparedness for Medicare demonstrations; Implementation of CARES Act (P.L. 116-136); HEROES Act (H.R. 6800); Health, Economic Assistance, Liability Protection and Schools (HEALS) Act; Strengthening America's Strategic National Stockpile Act (H.R. 7574); Make PPE in America Act (S. 4578/H.R. 8324); Medical Supplies for Pandemics Act (H.R. 6531).
Medical Supplies for Pandemics Act of 2020
Client: OWENS & MINOR, INC. · Firm: AKIN GUMP STRAUSS HAUER & FELD
COVID-19 pandemic response, supply chain issues and collaboration with federal government; Disaster preparedness for Medicare demonstrations; Implementation of CARES Act (P.L. 116-136); HEROES Act (H.R. 6800); Health, Economic Assistance, Liability Protection and Schools (HEALS) Act; Strengthening America's Strategic National Stockpile Act (H.R. 7574); Make PPE in America Act (S. 4578/H.R. 8324); Medical Supplies for Pandemics Act (H.R. 6531); FY 2021 National Defense Authorization Act (H.R. 6395); FY 2021 Consolidated Appropriations Act (H.R. 133); Issues related to the health care supply chain and COVID-19 response.
Medical Supplies for Pandemics Act of 2020
Client: GLOBAL HEALTHCARE EXCHANGE, LLC · Firm: AKIN GUMP STRAUSS HAUER & FELD
COVID-19 pandemic response; issues related to the health care supply chain; The Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act (H.R. 6800); The Medical Supplies for Pandemics Act (H.R. 6531).
Medical Supplies for Pandemics Act of 2020
Client: GLOBAL HEALTHCARE EXCHANGE, LLC · Firm: AKIN GUMP STRAUSS HAUER & FELD
COVID-19 pandemic response; issues related to the health care supply chain; Medical Supplies for Pandemics Act (H.R. 6531); Implementation of CARES Act (P.L. 116-136); Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act (H.R. 6800); Health, Economic Assistance, Liability Protection and Schools (HEALS) Act; Strengthening America's Strategic National Stockpile Act (H.R. 7574); Make PPE in America Act (S. 4578/H.R. 8324).
Sec. S965 and GILTI.; COVID-19 tax issues including, Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), the CARES Act (S. 3548/H.R. 748) the HEROES Act (H.R. 6800), Consolidated Appropriations Act, 2021 (H.R. 133)
Medicare and Medicaid coverage and reimbursement of laboratory tests; Data analytics to inform policy making; COVID-19 relief and response initiatives; the HEROES Act (H.R. 6800), and the Health, Economic Assistance, Liability Protection and Schools (HEALS) Act.
COVID-19 pandemic response, supply chain issues and collaboration with federal government; Disaster preparedness for Medicare demonstrations; Implementation of CARES Act (P.L. 116-136); HEROES Act (H.R. 6800); Health, Economic Assistance, Liability Protection and Schools (HEALS) Act; Strengthening America's Strategic National Stockpile Act (H.R. 7574); Make PPE in America Act (S. 4578/H.R. 8324); Medical Supplies for Pandemics Act (H.R. 6531); FY 2021 National Defense Authorization Act (H.R. 6395); FY 2021 Consolidated Appropriations Act (H.R. 133); Issues related to the health care supply chain and COVID-19 response.
COVID-19 pandemic response and collaboration with federal government; Implementation of CARES Act (P.L. 116-136); HEROES Act (H.R. 6800).
COVID-19 health care issues, including supply chain issues, hospitals and other relief funding within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), the CARES Act (S. 3548/H.R. 748), and HEROES Act (HR 6800).
COVID-19 tax issues including, Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), and the CARES Act (S. 3548/H.R. 748); Sec. S965 and GILTI.; the HEROES Act (H.R. 6800).
The Heroes Act
Client: GLOBAL HEALTHCARE EXCHANGE, LLC · Firm: AKIN GUMP STRAUSS HAUER & FELD
COVID-19 pandemic response; issues related to the health care supply chain; The Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act (H.R. 6800); The Medical Supplies for Pandemics Act (H.R. 6531).
The Heroes Act
Client: GLOBAL HEALTHCARE EXCHANGE, LLC · Firm: AKIN GUMP STRAUSS HAUER & FELD
COVID-19 pandemic response; issues related to the health care supply chain; Medical Supplies for Pandemics Act (H.R. 6531); Implementation of CARES Act (P.L. 116-136); Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act (H.R. 6800); Health, Economic Assistance, Liability Protection and Schools (HEALS) Act; Strengthening America's Strategic National Stockpile Act (H.R. 7574); Make PPE in America Act (S. 4578/H.R. 8324).
Technology research; Telemedicine and connected care; Remote patient monitoring; Implementation of Patient Protection and Affordable Care Act (H.R. 3590/P.L. 111-148); Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); The implementation of The Medicare Access and CHIP re authorization Act (H.R. 2); Diabetic retinopathy; safe patient handling, FDA reform; Sepsis funding and education; Diabetic Vision Loss and Blindness Prevention Act of 2019 (H.R.5254).; COVID-19 health care legislative and regulatory implementation and funding issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), the CARES Act (S. 3548/H.R. 748) and the HEROES Act (H.R. 6800), Consolidated Appropriations Act, 2021 (H.R. 133)
COVID-19 health care issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the COVID-19 health care issues issues within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), and the CARES Act (S. 3548/H.R. 748); Implementation of Patient Protection and Affordable Care Act (H.R. 3590/Pub. L. 111-148); Telemedicine and connected care; Remote patient monitoring; Health Care and Education Reconciliation Act (H.R. 4872/Pub. L. 111-152); The implementation of the Medicare Access and CHIP reauthorization Act (H.R. 2); Safe patient handling, FDA reform; Sepsis funding and education; Further Consolidated Appropriations Act, 2020, (H.R.1865); Diabetic Vision Loss and Blindness Prevention Act of 2019 (H.R.5254).; COVID-19 health care issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the COVID-19 health care issues issues within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), the CARES Act (S. 3548/H.R. 748); the HEROES Act (H.R. 6800)
COVID-19 pandemic response, supply chain issues and collaboration with federal government; Disaster preparedness for Medicare demonstrations; Implementation of CARES Act (P.L. 116-136); HEROES Act (H.R. 6800); Health, Economic Assistance, Liability Protection and Schools (HEALS) Act; Strengthening America's Strategic National Stockpile Act (H.R. 7574); Make PPE in America Act (S. 4578/H.R. 8324); Medical Supplies for Pandemics Act (H.R. 6531).
Technology research; Telemedicine and connected care; Remote patient monitoring; Implementation of Patient Protection and Affordable Care Act (H.R. 3590/P.L. 111-148); Health Care and Education Reconciliation Act (H.R. 4872/P.L. 111-152); The implementation of The Medicare Access and CHIP re authorization Act (H.R. 2); Diabetic retinopathy; safe patient handling, FDA reform; Sepsis funding and education; Diabetic Vision Loss and Blindness Prevention Act of 2019 (H.R.5254).; COVID-19 health care legislative and regulatory implementation and funding issues, including ventilators, device and supply chain issues, hospitals and other relief funding within the Families First Coronavirus Response Act (H.R. 6201), Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074), the CARES Act (S. 3548/H.R. 748) and the HEROES Act (H.R. 6800), Consolidated Appropriations Act, 2021 (H.R. 133)
2023 · fourth_quarter · Q4
Issues related to Medicare reimbursement for an implantable device; Issues relating to Medicare Physician Fee Schedule (PFS).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS)
LABORATORY CORPORATION OF AMERICA HOLDINGS via AKIN GUMP STRAUSS HAUER & FELD
2023 · fourth_quarter · Q4
Fentanyl testing strips and use scenarios; issues related to toxicology testing.
Issues related to Medicare reimbursement for toxicology testing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Health & Human Services, Dept of (HHS), Substance Abuse & Mental Health Services Administration (SAMHSA), Veterans Affairs, Dept of (VA), White House Office
INARI MEDICAL via AKIN GUMP STRAUSS HAUER & FELD
2023 · fourth_quarter · 4T
Education and awareness of medical device treatments for blood clots.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EQUIFAX INC. via AKIN GUMP STRAUSS HAUER & FELD
2023 · fourth_quarter · Q4
Issues related to Medicaid eligibility data.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
MAINSTAY MEDICAL, LTD. via AKIN GUMP STRAUSS HAUER & FELD
2023 · fourth_quarter · Q4
Medical device coverage and access; Private insurance coverage of peripheral nerve stimulation.
Issues related to reimbursement of medical devices for pain management; Medicare coverage of peripheral nerve stimulation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RESMED CORP. via AKIN GUMP STRAUSS HAUER & FELD
2023 · fourth_quarter · Q4
Issues regarding Medicare reimbursement for respiratory devices (H.R. 5555 - DMEPOS Relief Act of 2023).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
SHATTERPROOF via AKIN GUMP STRAUSS HAUER & FELD
2023 · fourth_quarter · Q4
Issues related to Substance Use Disorder programs; S. 2433 - SUPPORT for Patients and Communities Reauthorization Act of 2023 funding; Issues related to behavioral health; Methods to assess addiction treatment facilities quality and accessibility, including launch of the "Shatterproof Treatment Atlas" to help patients find treatment options.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
MILLENNIUM HEALTH via AKIN GUMP STRAUSS HAUER & FELD
2023 · fourth_quarter · 4T
Coverage of laboratory drug testing services, opioid crisis.
Coverage of laboratory drug testing services, opioid crisis.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SHATTERPROOF via AKIN GUMP STRAUSS HAUER & FELD
2023 · third_quarter · Q3
Issues related to Substance Use Disorder programs; S. 2433 - SUPPORT for Patients and Communities Reauthorization Act of 2023 funding; Issues related to behavioral health.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
RESMED CORP. via AKIN GUMP STRAUSS HAUER & FELD
2023 · third_quarter · Q3
Issues regarding Medicare reimbursement for respiratory devices.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
SIEMENS HEALTHINEERS (FKA VARIAN MEDICAL SYSTEMS, INC.) via AKIN GUMP STRAUSS HAUER & FELD
2023 · third_quarter · Q3
Issues related to radiation therapy reimbursement and alternative payment models; issues related to telehealth; issues related to laboratory testing; S. 1544/H.R. 1199 - Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2023.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
EQUIFAX INC. via AKIN GUMP STRAUSS HAUER & FELD
2023 · third_quarter · Q3
Issues related to Medicaid eligibility data.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
LABORATORY CORPORATION OF AMERICA HOLDINGS via AKIN GUMP STRAUSS HAUER & FELD
2023 · third_quarter · Q3
Issues related to Medicare reimbursement for toxicology testing.
Fentanyl testing strips and use scenarios; issues related to toxicology testing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Substance Abuse & Mental Health Services Administration (SAMHSA), Transportation, Dept of (DOT), White House Office
SENSEONICS INCORPORATED via AKIN GUMP STRAUSS HAUER & FELD
2023 · third_quarter · Q3
Issues related to Medicare reimbursement for an implantable device; Issues relating to Medicare Physician Fee Schedule (PFS).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS)
MILLENNIUM HEALTH via AKIN GUMP STRAUSS HAUER & FELD
2023 · third_quarter · Q3
Medicare and Medicaid coverage and reimbursement of laboratory tests; Data analytics to inform policy making.
Issues related to opioids/substance use; Issues impacting toxicology testing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MAINSTAY MEDICAL, LTD. via AKIN GUMP STRAUSS HAUER & FELD
2023 · third_quarter · Q3
Medical device coverage and access.
Issues related to reimbursement of medical devices for pain management.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
INARI MEDICAL via AKIN GUMP STRAUSS HAUER & FELD
2023 · third_quarter · Q3
Reimbursement issues regarding clot removing medical devices.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
QNOVIA, INC. via AKIN GUMP STRAUSS HAUER & FELD
2023 · third_quarter · RR
Smoking cessation.
RESMED CORP. via AKIN GUMP STRAUSS HAUER & FELD
2023 · second_quarter · Q2
Issues regarding Medicare reimbursement for respiratory devices.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES
SJ MEDCONNECT via AKIN GUMP STRAUSS HAUER & FELD
2023 · second_quarter · Q2
GME residency and fellowship platforms and real-time data; awarding new residency/GME slots, use of real time data when making residency position awards.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Science & Technology Policy (OSTP), SENATE, White House Office
SENSEONICS INCORPORATED via AKIN GUMP STRAUSS HAUER & FELD
2023 · second_quarter · Q2
Issues relates to Medicare reimbursement for an implantable device; Issues relating to Medicare Physician Fee Schedule (PFS).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS)
PARTNERSHIP FOR MEDICAID HOME-BASED CARE via AKIN GUMP STRAUSS HAUER & FELD
2023 · second_quarter · Q2
Medicaid home- and community-based services funding; Issues related to funding for Medicaid home and community-based services, alignment of Medicare and Medicaid Programs to protect the dually eligible population, the definition of private duty nursing, and section 409 of H.R. 6000, the Cures 2.0 Act. Centers for Medicare and Medicaid Services Ensuring Access to Medicaid Services (CMS-2442-P) Proposed Rule.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MILLENNIUM HEALTH via AKIN GUMP STRAUSS HAUER & FELD
2023 · second_quarter · Q2
Opioids/substance use; Issues impacting laboratories; telehealth.
Medicare and Medicaid coverage and reimbursement of laboratory tests; Data analytics to inform policy making.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MAINSTAY MEDICAL, LTD. via AKIN GUMP STRAUSS HAUER & FELD
2023 · second_quarter · Q2
Issues related to reimbursement of medical devices for pain management.
Medical device coverage and access.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
MAINSTAY MEDICAL, LTD. via AKIN GUMP STRAUSS HAUER & FELD
2023 · second_quarter · Q2
Issues related to reimbursement of medical devices for pain management.
Medical device coverage and access.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
SIEMENS HEALTHINEERS (FKA VARIAN MEDICAL SYSTEMS, INC.) via AKIN GUMP STRAUSS HAUER & FELD
2023 · second_quarter · Q2
Issues related to radiation therapy reimbursement and alternative payment models; issues related to telehealth; issues related to laboratory testing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
INARI MEDICAL via AKIN GUMP STRAUSS HAUER & FELD
2023 · second_quarter · Q2
Education and awareness of medical device treatments for blood clots.
Fiscal Year 2024 Centers for Disease Control and Prevention (CDC) appropriations for Deep Vein Thrombosis (DVT) and Pulmonary Embolisms (PE) education and awareness.
Reimbursement issues regarding clot removing medical devices.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SHATTERPROOF via AKIN GUMP STRAUSS HAUER & FELD
2023 · second_quarter · Q2
Issues related to Substance Use Disorder programs; S.3476 - SUPPORT Act of 2022 funding; Issues related to behavioral health.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ARCHER SYSTEMS LLC via AKIN GUMP STRAUSS HAUER & FELD
2023 · second_quarter · Q2
Issues related to Medicare as Secondary Payer.
Filing targets: Centers For Medicare and Medicaid Services (CMS)
EUROAPI via AKIN GUMP STRAUSS HAUER & FELD
2023 · second_quarter · Q2
Issues related to onshoring biopharmaceutical manufacturing.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Science & Technology Policy (OSTP), SENATE, White House Office
SJ MEDCONNECT via AKIN GUMP STRAUSS HAUER & FELD
2023 · first_quarter · Q1
GME residency and fellowship platforms and real-time data.
GME residency and fellowship platforms and real-time data; awarding new residency/GME slots, use of real time data when making residency position awards.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Science & Technology Policy (OSTP), SENATE, White House Office
SENSEONICS INCORPORATED via AKIN GUMP STRAUSS HAUER & FELD
2023 · first_quarter · Q1
Issues relates to Medicare reimbursement for an implantable device; Issues relating to Medicare Physician Fee Schedule (PFS).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS)
MAINSTAY MEDICAL, LTD. via AKIN GUMP STRAUSS HAUER & FELD
2023 · first_quarter · Q1
Issues related to reimbursement of medical devices for pain management.
Medical device coverage and access.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
INARI MEDICAL via AKIN GUMP STRAUSS HAUER & FELD
2023 · first_quarter · Q1
Reimbursement issues regarding clot removing medical devices.
Education and awareness of medical device treatments for blood clots.
Fiscal Year 2024 Centers for Disease Control and Prevention (CDC) appropriations for Deep Vein Thrombosis (DVT) and Pulmonary Embolisms (PE) education and awareness.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ARCHER SYSTEMS LLC via AKIN GUMP STRAUSS HAUER & FELD
2023 · first_quarter · Q1
Issues related to Medicare as Secondary Payer.
Filing targets: Centers For Medicare and Medicaid Services (CMS)
EUROAPI via AKIN GUMP STRAUSS HAUER & FELD
2023 · first_quarter · RR
Onshoring biomanufacturing of pharmaceutical precursors.
Onshoring biomanufacturing of pharmaceutical precursors.
Onshoring biomanufacturing of pharmaceutical precursors.
ARCHER SYSTEMS LLC via AKIN GUMP STRAUSS HAUER & FELD
2023 · first_quarter · RR
The Centers for Medicare & Medicaid Services and resolution of various liens on certain legal settlements.
SJ MEDCONNECT via AKIN GUMP STRAUSS HAUER & FELD
2022 · fourth_quarter · Q4
GME residency and fellowship platforms and real-time data.
GME residency and fellowship platforms and real-time data.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Science & Technology Policy (OSTP), SENATE, White House Office
RESMED CORP. via AKIN GUMP STRAUSS HAUER & FELD
2022 · fourth_quarter · Q4
Digital health regulation and reimbursement; data privacy; respiratory care.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SENSEONICS INCORPORATED via AKIN GUMP STRAUSS HAUER & FELD
2022 · fourth_quarter · Q4
Issues relates to Medicare reimbursement for an implantable device; Issues relating to Medicare Physician Fee Schedule (PFS).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS)
WCNSM ENTERPRISE, LLX via AKIN GUMP STRAUSS HAUER & FELD
2022 · fourth_quarter · RR
Identify and pursue federal funding of new air purification and disinfection systems.
Identify and pursue federal funding of new air purification and disinfection systems.
Identify and pursue federal funding of new air purification and disinfection systems.
SJ MEDCONNECT via AKIN GUMP STRAUSS HAUER & FELD
2022 · third_quarter · Q3
GME residency and fellowship platforms and real-time data.
GME residency and fellowship platforms and real-time data.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
SIEMENS HEALTHINEERS (FKA VARIAN MEDICAL SYSTEMS, INC.) via AKIN GUMP STRAUSS HAUER & FELD
2022 · third_quarter · Q3
Issues re: access to cancer care and treatment; issues re: medical device remanufacturing
Issues related to radiation therapy reimbursement and alternative payment models; issues related to telehealth; issues related to COVID-19 testing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
SENSEONICS INCORPORATED via AKIN GUMP STRAUSS HAUER & FELD
2022 · third_quarter · Q3
Issues relates to Medicare reimbursement for an implantable device; Issues relating to Medicare Physician Fee Schedule (PFS).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
INARI MEDICAL via AKIN GUMP STRAUSS HAUER & FELD
2022 · third_quarter · Q3
Education and awareness of medical device treatments for blood clots.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EMED, LLC via AKIN GUMP STRAUSS HAUER & FELD
2022 · third_quarter · Q3
Advocacy related to COVID-19 testing services, at-home testing and treatment, and telehealth.
Reimbursement issues related to COVID testing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
RESMED CORP. via AKIN GUMP STRAUSS HAUER & FELD
2022 · third_quarter · Q3
Digital health regulation and reimbursement; data privacy; respiratory care.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MILLENNIUM HEALTH via AKIN GUMP STRAUSS HAUER & FELD
2022 · third_quarter · Q3
Opioids/substance use; drug testing.
Medicare and Medicaid coverage and reimbursement of laboratory tests; Data analytics to inform policy making; COVID-19 relief and response initiatives.
Opioids/substance use; Issues impacting laboratories; telehealth.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SJ MEDCONNECT via AKIN GUMP STRAUSS HAUER & FELD
2022 · third_quarter · RR
Lobby for the use of real-time information in residency slot distribution and demographic information when awarding GME slots by CMS.
BOOZ ALLEN HAMILTON INC. via AKIN GUMP STRAUSS HAUER & FELD
2022 · third_quarter · RR
Artificial intelligence; electronic health record modernization; cybersecurity; FY23 National Defense Authorization Act
Artificial intelligence; electronic health record modernization; cybersecurity; FY23 National Defense Authorization Act
Artificial intelligence; electronic health record modernization; cybersecurity; FY23 National Defense Authorization Act
SIEMENS HEALTHINEERS (FKA VARIAN MEDICAL SYSTEMS, INC.) via AKIN GUMP STRAUSS HAUER & FELD
2022 · second_quarter · Q2
H.R. 4479/S. 2609 - the Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2021; issues re: radiation therapy reimbursement and alternative payment models; issues re: telehealth; issues re: COVID-19 testing.
General issues regarding access to cancer care and treatment; issues re: right to repair proposals; issues re: medical device remanufacturing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
SENSEONICS INCORPORATED via AKIN GUMP STRAUSS HAUER & FELD
2022 · second_quarter · Q2
Issues relates to Medicare reimbursement for an implantable device; Issues relating to Medicare Physician Fee Schedule (PFS)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
INARI MEDICAL via AKIN GUMP STRAUSS HAUER & FELD
2022 · second_quarter · Q2
Education and awareness of medical device treatments for blood clots.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EMED, LLC via AKIN GUMP STRAUSS HAUER & FELD
2022 · second_quarter · Q2
Advocacy related to COVID-19 testing services.
Reimbursement issues related to COVID testing
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
SIEMENS HEALTHINEERS (FKA VARIAN MEDICAL SYSTEMS, INC.) via AKIN GUMP STRAUSS HAUER & FELD
2022 · first_quarter · Q1
H.R. 4479, the Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2021; issues related to radiation therapy reimbursement and alternative payment models; issues related to telehealth; issues related to COVID-19 testing; H.R. 4479/S. 2609 - the Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2021.
General issues regarding access to cancer care and treatment.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
SENSEONICS INCORPORATED via AKIN GUMP STRAUSS HAUER & FELD
2022 · first_quarter · Q1
Issues relates to Medicare reimbursement for an implantable device; Issues relating to Medicare Physician Fee Schedule (PFS)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MILLENNIUM HEALTH via AKIN GUMP STRAUSS HAUER & FELD
2022 · first_quarter · Q1
Medicare and Medicaid coverage and reimbursement of laboratory tests; Data analytics to inform policy making; COVID-19 relief and response initiatives.
Opioids/substance use; Issues impacting laboratories; Comprehensive Addiction and Recovery Act (CARA) 3.0 (S.987)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
INARI MEDICAL via AKIN GUMP STRAUSS HAUER & FELD
2022 · first_quarter · Q1
Education and awareness of medical device treatments for blood clots.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
EMED, LLC via AKIN GUMP STRAUSS HAUER & FELD
2022 · first_quarter · Q1
Reimbursement issues related to COVID testing
Advocacy related to COVID-19 testing services.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
MAINSTAY MEDICAL, LTD. via AKIN GUMP STRAUSS HAUER & FELD
2022 · first_quarter · RR
Advocacy related to non-opioid pain management devices.
Advocacy related to non-opioid pain management devices.
RESMED CORP. via AKIN GUMP STRAUSS HAUER & FELD
2021 · fourth_quarter · Q4
Issues regarding Medicare reimbursement for DMEPOS and remote therapeutic monitoring services; issues regarding supply chain
SIEMENS HEALTHINEERS (FKA VARIAN MEDICAL SYSTEMS, INC.) via AKIN GUMP STRAUSS HAUER & FELD
2021 · fourth_quarter · Q4
General issues regarding access to cancer care and treatment.
Issues related to Medicare reimbursement for oncology care and alternative payment models; issues related to telehealth; issues related to COVID-19 testing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), SENATE, U.S. Trade Representative (USTR), White House Office
SENSEONICS INCORPORATED via AKIN GUMP STRAUSS HAUER & FELD
2021 · fourth_quarter · Q4
Issues relates to Medicare reimbursement for an implantable device; Issues relating to Medicare Physician Fee Schedule (PFS)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MILLENNIUM HEALTH via AKIN GUMP STRAUSS HAUER & FELD
2021 · fourth_quarter · Q4
Medicare and Medicaid coverage and reimbursement of laboratory tests; Data analytics to inform policy making; COVID-19 relief and response initiatives.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EMED, LLC via AKIN GUMP STRAUSS HAUER & FELD
2021 · fourth_quarter · Q4
Advocacy related to COVID-19 testing services.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
CITY OF HOUSTON via AKIN GUMP STRAUSS HAUER & FELD
2021 · fourth_quarter · Q4
Advocacy around North Houston Highway Improvement project and blocked grade crossings.
Federal support for COVID-19 testing and ETHAN telemedicine.; Funding for ETHAN telemedicine program; federal support for COVID-19 testing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Health & Human Services, Dept of (HHS), Transportation, Dept of (DOT)
EMED, LLC via AKIN GUMP STRAUSS HAUER & FELD
2021 · fourth_quarter · RR
COVID-19 testing.
COVID-19 testing.
MILLENNIUM HEALTH via AKIN GUMP STRAUSS HAUER & FELD
2021 · third_quarter · Q3
Medicare and Medicaid coverage and reimbursement of laboratory tests; Data analytics to inform policy making; COVID-19 relief and response initiatives.
Opioids/substance use; laboratories; Comprehensive Addiction and Recovery Act (CARA) 3.0 (S.987)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
LET'SGETCHECKED via AKIN GUMP STRAUSS HAUER & FELD
2021 · third_quarter · Q3
Issues related COVID-19 and other laboratory testing.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SENSEONICS INCORPORATED via AKIN GUMP STRAUSS HAUER & FELD
2021 · third_quarter · Q3
Issues relates to Medicare reimbursement for an implantable device.; Issues with Medicare reimbursement; Issues relating to Medicare Physician Fee Schedule (PFS)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SIGHT SCIENCES, INC. via AKIN GUMP STRAUSS HAUER & FELD
2021 · third_quarter · Q3
Medicare reimbursement issues for medical device.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
INARI MEDICAL via AKIN GUMP STRAUSS HAUER & FELD
2021 · third_quarter · Q3
Defense Production Act allocation of catheter supply chain issues.
Medicare coverage of transvenous (catheter) pulmonary embolectomy.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
TWENTY HOLDINGS INC via AKIN GUMP STRAUSS HAUER & FELD
2021 · third_quarter · Q3
COVID-19 response; contact tracing; vaccines.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SIEMENS HEALTHINEERS (FKA VARIAN MEDICAL SYSTEMS, INC.) via AKIN GUMP STRAUSS HAUER & FELD
2021 · third_quarter · Q3
Issues related to radiation therapy reimbursement and alternative payment models; issues related to telehealth.; issues related to COVID-19 testing.
General issues regarding access to cancer care and treatment.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Science & Technology Policy (OSTP), SENATE, White House Office
CITY OF HOUSTON via AKIN GUMP STRAUSS HAUER & FELD
2021 · third_quarter · Q3
Federal support for COVID-19 testing and ETHAN telemedicine; Funding for ETHAN telemedicine program; federal support for COVID-19 testing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Health & Human Services, Dept of (HHS), Housing & Urban Development, Dept of (HUD), Transportation, Dept of (DOT)
MILLENNIUM HEALTH via AKIN GUMP STRAUSS HAUER & FELD
2021 · second_quarter · Q2
Medicare and Medicaid coverage and reimbursement of laboratory tests; Data analytics to inform policy making; COVID-19 relief and response initiatives.
Opioids/substance use; laboratories; Comprehensive Addiction and Recovery Act (CARA) 3.0 (S.987)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
LET'SGETCHECKED via AKIN GUMP STRAUSS HAUER & FELD
2021 · second_quarter · Q2
Issues related COVID-19 and other laboratory testing.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
INARI MEDICAL via AKIN GUMP STRAUSS HAUER & FELD
2021 · second_quarter · Q2
Medicare coverage of transvenous (catheter) pulmonary embolectomy.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SENSEONICS INCORPORATED via AKIN GUMP STRAUSS HAUER & FELD
2021 · second_quarter · Q2
Issues relates to Medicare reimbursement for an implantable device.; Issues with Medicare reimbursement; Issues relating to Medicare Physician Fee Schedule (PFS)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SIGHT SCIENCES, INC. via AKIN GUMP STRAUSS HAUER & FELD
2021 · second_quarter · Q2
Medicare reimbursement issues for medical device.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
TWENTY HOLDINGS INC via AKIN GUMP STRAUSS HAUER & FELD
2021 · second_quarter · Q2
COVID-19 response; contact tracing; vaccines.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SIEMENS HEALTHINEERS (FKA VARIAN MEDICAL SYSTEMS, INC.) via AKIN GUMP STRAUSS HAUER & FELD
2021 · second_quarter · Q2
Issues related to radiation therapy reimbursement and alternative payment models; issues related to telehealth.; issues related to COVID-19 testing.
General issues regarding access to cancer care and treatment.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
CITY OF HOUSTON via AKIN GUMP STRAUSS HAUER & FELD
2021 · second_quarter · Q2
Federal support for COVID-19 testing and ETHAN telemedicine.
Filing targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Housing & Urban Development, Dept of (HUD), Transportation, Dept of (DOT)
CALOPTIMA via AKIN GUMP STRAUSS HAUER & FELD
2021 · second_quarter · 2T
FMAP increase, COVID testing and provider relief funding, MFAR
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
CENTRIENT PHARMACEUTICALS LLC via AKIN GUMP STRAUSS HAUER & FELD
2021 · second_quarter · Q2
Advocacy regarding solutions for onshore supply chain and manufacturing of critical medicines back to the United States.
Advocacy regarding solutions for onshore supply chain and manufacturing of critical medicines back to the United States.
Filing targets: Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Security Council (NSC), SENATE
INARI MEDICAL via AKIN GUMP STRAUSS HAUER & FELD
2021 · second_quarter · RR
Issues related to Medicare reimbursement.
Issues related to Medicare reimbursement.
OWENS & MINOR, INC. via AKIN GUMP STRAUSS HAUER & FELD
2021 · first_quarter · 1T
COVID-19 pandemic response and preparedness; Stockpile and supply chain issues and collaboration with federal government; Implementation of CARES Act (P.L. 116-136) and relief funding.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE
SIEMENS HEALTHINEERS (FKA VARIAN MEDICAL SYSTEMS, INC.) via AKIN GUMP STRAUSS HAUER & FELD
2021 · first_quarter · Q1
General issues regarding access to cancer care and treatment.
Issues related to radiation therapy reimbursement and alternative payment models; issues related to telehealth.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
TWENTY HOLDINGS INC via AKIN GUMP STRAUSS HAUER & FELD
2021 · first_quarter · Q1
COVID-19 testing, contact tracing, vaccines, pandemic response and preparedness; technology funding and collaboration with federal agencies; American Rescue Plan Act (P.L. 117-2); FY 2022 appropriations.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, White House Office
SENSEONICS INCORPORATED via AKIN GUMP STRAUSS HAUER & FELD
2021 · first_quarter · Q1
Issues relates to Medicare reimbursement for an implantable device.; Issues with Medicare reimbursement; Issues relating to Medicare Physician Fee Schedule (PFS)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
OWENS & MINOR, INC. via AKIN GUMP STRAUSS HAUER & FELD
2021 · first_quarter · Q1
COVID-19 pandemic response and preparedness; Stockpile and supply chain issues and collaboration with federal government; Implementation of CARES Act (P.L. 116-136) and relief funding.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE
MILLENNIUM HEALTH via AKIN GUMP STRAUSS HAUER & FELD
2021 · first_quarter · Q1
Medicare and Medicaid coverage and reimbursement of laboratory tests; Data analytics to inform policy making; COVID-19 relief and response initiatives.
Opioids/substance use; laboratories; Comprehensive Addiction and Recovery Act (CARA) 3.0 (S.987)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
LET'SGETCHECKED via AKIN GUMP STRAUSS HAUER & FELD
2021 · first_quarter · Q1
Issues related to COVID-19 laboratory testing.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
IMCS GROUP INC. via AKIN GUMP STRAUSS HAUER & FELD
2021 · first_quarter · Q1
Issues related to federal contracts and reimbursement for behavioral health.
Issues related to federal contracts and reimbursement for behavioral health.; FY 2022 Labor-HHS Appropriations.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Office of Management & Budget (OMB), SENATE
HILL-ROM via AKIN GUMP STRAUSS HAUER & FELD
2021 · first_quarter · 1T
Issues related to reimbursement for diabetic retinopathy.
Technology research; Telemedicine and connected care.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Health & Human Services, Dept of (HHS)
CITY OF HOUSTON via AKIN GUMP STRAUSS HAUER & FELD
2021 · first_quarter · Q1
Federal support for COVID-19 testing and ETHAN telemedicine.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Transportation, Dept of (DOT)
CALOPTIMA via AKIN GUMP STRAUSS HAUER & FELD
2021 · first_quarter · Q1
FMAP increase, COVID testing and provider relief funding, MFAR
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AKEBIA THERAPEUTICS, INC. via AKIN GUMP STRAUSS HAUER & FELD
2021 · first_quarter · Q1
Issues with Medicare reimbursement; Issues relating to CY 21 End Stage Renal Disease (ESRD) Prospective Payment System; Medicare flexibility related to COVID-19 pandemic outbreak.
Issues with Medicare reimbursement; Issues relating to CY 21 End Stage Renal Disease (ESRD) Prospective Payment System; Medicare flexibility related to COVID-19 pandemic outbreak.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
CENTRIENT PHARMACEUTICALS LLC via AKIN GUMP STRAUSS HAUER & FELD
2021 · first_quarter · Q1
Advocacy regarding solutions for onshore manufacturing of critical medicines back to the United States.
Advocacy regarding solutions for onshore manufacturing of critical medicines back to the United States.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Security Agency (NSA), Natl Security Council (NSC), SENATE
Identify and pursue federal funding of new air purification and disinfection systems.
Artificial intelligence; electronic health record modernization; cybersecurity; FY23 National Defense Authorization Act